MA Vadas

2.3k total citations
38 papers, 1.9k citations indexed

About

MA Vadas is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, MA Vadas has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 10 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in MA Vadas's work include Immune Response and Inflammation (21 papers), Immune Cell Function and Interaction (16 papers) and Cell Adhesion Molecules Research (5 papers). MA Vadas is often cited by papers focused on Immune Response and Inflammation (21 papers), Immune Cell Function and Interaction (16 papers) and Cell Adhesion Molecules Research (5 papers). MA Vadas collaborates with scholars based in Australia, United Kingdom and United States. MA Vadas's co-authors include Angel F. López, D Metcalf, Nicos A. Nicola, C. Glenn Begley, SC Clark, M Shannon, CJ Sanderson, Jennifer R. Gamble, DJ Williamson and GR Johnson and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Bioinformatics.

In The Last Decade

MA Vadas

38 papers receiving 1.9k citations

Peers

Countries citing papers authored by MA Vadas

Since Specialization

Citations

This map shows the geographic impact of MA Vadas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MA Vadas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MA Vadas more than expected).

Fields of papers citing papers by MA Vadas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MA Vadas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MA Vadas. The network helps show where MA Vadas may publish in the future.

Co-authorship network of co-authors of MA Vadas

This figure shows the co-authorship network connecting the top 25 collaborators of MA Vadas. A scholar is included among the top collaborators of MA Vadas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MA Vadas. MA Vadas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Active subnetwork recovery with a mechanism-dependent scoring function; with application to angiogenesis and organogenesis studies 2013 ·Bioinformatics ·(unknown), (unknown), (unknown), (unknown), MA Vadas	5
2	Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukin-3 1996 ·Blood ·Yeesim Khew‐Goodall, C M Butcher, (unknown), Shawn D. Newlands, Eija Korpelainen, (unknown), MC Berndt, Angel F. López, Jennifer R. Gamble, MA Vadas	70
3	Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonist 1996 ·Blood ·Qing‐Yuan Sun, Joanna M. Woodcock, Aaron P. Rapoport, (unknown), Eija Korpelainen, (unknown), Gregory J. Goodall, William Smith, Jennifer R. Gamble, MA Vadas, Angel F. López	94
4	Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonist 1996 ·Blood ·Qing‐Yuan Sun, Joanna M. Woodcock, Aaron P. Rapoport, (unknown), Eija Korpelainen, (unknown), Gregory J. Goodall, William Smith, Jennifer R. Gamble, MA Vadas, Angel F. López	5
5	Regulation of granulocyte-macrophage colony-stimulating factor and E- selectin expression in endothelial cells by cyclosporin A and the T- cell transcription factor NFAT 1995 ·Blood ·(unknown), Andrew G. Bert, (unknown), Jennifer R. Gamble, MA Vadas, (unknown)	8
6	Interferon-gamma upregulates interleukin-3 (IL-3) receptor expression in human endothelial cells and synergizes with IL-3 in stimulating major histocompatibility complex class II expression and cytokine production 1995 ·Blood ·Eija Korpelainen, Jennifer R. Gamble, William Smith, Mara Dottore, MA Vadas, Angel F. López	36
7	Identification of residues in the first and fourth helices of human granulocyte-macrophage colony-stimulating factor involved in biologic activity and in binding to the alpha- and beta-chains of its receptor 1994 ·Blood ·(unknown), Bronwyn Cambareri, Mara Dottore, Joanna M. Woodcock, (unknown), MA Vadas, M Shannon, Angel F. López	1
8	Requirement for nuclear factor (NF)-kappa B p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter 1994 ·Blood ·(unknown), (unknown), (unknown), Steve Gerondakis, MA Vadas, M Shannon	7
9	A cytokine receptor gene cluster in the X-Y pseudoautosomal region? 1993 ·Blood ·Eric J. Kremer, Elizabeth Baker, (unknown), Rima Slim, Hilary A. Phillips, (unknown), Angel F. López, Christine Petit, MA Vadas, GR Sutherland	39
10	Human interleukin-3 mRNA accumulation is controlled at both the transcriptional and posttranscriptional level 1991 ·Blood ·(unknown), (unknown), Angel F. López, (unknown), MA Vadas, M Shannon	28
11	Recombinant human interleukin-3 and granulocyte-macrophage colony- stimulating factor show common biological effects and binding characteristics on human monocytes 1989 ·Blood ·MJ Elliott, MA Vadas, (unknown), LS Park, LB To, (unknown), SC Clark, Angel F. López	8
12	Interleukin-5 is at 5q31 and is deleted in the 5q- syndrome 1988 ·Blood ·GR Sutherland, (unknown), (unknown), HD Campbell, IG Young, CJ Sanderson, O. Margaret Garson, Angel F. López, MA Vadas	8
13	Interleukin-5 is at 5q31 and is deleted in the 5q- syndrome 1988 ·Blood ·GR Sutherland, Elizabeth Baker, (unknown), HD Campbell, IG Young, CJ Sanderson, O. Margaret Garson, Angel F. López, MA Vadas	74
14	Localization of the G-CSF gene on chromosome 17 proximal to the breakpoint in the t(15;17) in acute promyelocytic leukemia 1987 ·Blood ·(unknown), (unknown), M Shannon, O. Margaret Garson, (unknown), MA Vadas, GR Sutherland	1
15	Biologic properties in vitro of a recombinant human granulocyte- macrophage colony-stimulating factor 1986 ·Blood ·D Metcalf, C. Glenn Begley, GR Johnson, Nicos A. Nicola, MA Vadas, Angel F. López, DJ Williamson, GG Wong, SC Clark, (unknown)	380
16	Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors 1986 ·Blood ·C. Glenn Begley, Angel F. López, Nicos A. Nicola, (unknown), MA Vadas, CJ Sanderson, D Metcalf	230
17	Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors 1986 ·Blood ·C. Glenn Begley, Angel F. López, Nicos A. Nicola, (unknown), MA Vadas, CJ Sanderson, D Metcalf	24
18	The clonal proliferation in vitro of enriched populations of human promyelocytes and myelocytes 1985 ·Blood ·C. Glenn Begley, Angel F. López, MA Vadas, (unknown)	1
19	Eosinophil activation by colony-stimulating factor in man: metabolic effects and analysis by flow cytometry 1983 ·Blood ·MA Vadas, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	4
20	Interactions between human eosinophils and schistosomula of schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence 1979 ·The Journal of Experimental Medicine ·A Butterworth, MA Vadas, (unknown), Alain Dessein, (unknown), Barbara Sherry, GJ Gleich, (unknown)	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact